Victorian govt supports IDT to build Australia's first commercial antibody drug conjugate manufacturing facility
Singapore, May 7 -- IDT Australia has been awarded a Victoria State Government grant to part fund the establishment of Australia's first cGMP Antibody-Drug-Conjugate (ADC) manufacturing facility.
The grant from the Victorian Industry Investment Fund (VIIF) stream of the Victorian Jobs and Investment Fund (VJIF) is for IDT Australia's new $3.8 million commercial Contract Design and Manufacturing Organisation (CDMO) facility in Boronia, Victoria for ADCs - a new class of oncology drugs that precisely target cancer cells while sparing healthy ones.
IDT has established early relationships with ADC biotech companies including a master services agreement with Nagase & Co., a globally renowned Japanese pharmaceutical supplier, to develop and m...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.